EdgarLookup

Aspire Biopharma Holdings, Inc. — SCHEDULE 13G Filings

2 SCHEDULE 13G filings on record

This page lists all SCHEDULE 13G filings submitted to the SEC by Aspire Biopharma Holdings, Inc. (ASBPW), sorted by most recent first. Each row links to the full filing on EdgarLookup. Aspire Biopharma Holdings, Inc. has filed 2 SCHEDULE 13G documents with the SEC since 2021. To view all SEC filings by Aspire Biopharma Holdings, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-Q 10-Q/A 25-NSE 3 4 4/A 424B3 424B4 425 8-A12B 8-K 8-K/A CERT CORRESP DEF 14A DEFA14A DRS DRS/A DRSLTR EFFECT NT 10-K NT 10-Q PRE 14A RW S-1 S-1/A S-4 S-4/A SC 13D SC 13G SC 13G/A SCHEDULE 13G SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
SCHEDULE 13G 0001213900-26-015382 Feb 12, 2026
SCHEDULE 13G 0001493152-25-008412 Feb 26, 2025